Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: ChemMedChem. 2012 Mar 21;7(5):844–849. doi: 10.1002/cmdc.201200045

Figure 3.

Figure 3

Evaluation of halofuginone derivatives. Halofuginone (1 μM) inhibits P. berghei sporozoite load in HepG2 cells but N-acylated halofuginone derivatives (1 μM) are inactive. P. berghei parasite load in HepG2 cells was assessed by the relative luminescence signal 45 hours post-infection with a transgenic luciferase parasite reporter strain. Luminescence values were normalized to the DMSO control and reported as the average percent parasite load ± the standard deviation.